05/06/2024
3:46 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:05 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
3:35 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form ARS | |
03/27/2024
3:31 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024
3:31 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024
3:33 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form DEFA14A | |
02/20/2024
7:10 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
02/14/2024
1:35 PM | ARMISTICE CAPITAL, LLC (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
5:38 AM | MACQUARIE GROUP LTD (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
9:33 AM | MORGAN STANLEY (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G | |
02/07/2024
6:37 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
02/01/2024
8:57 PM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
8:58 PM | Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
8:58 PM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
8:58 PM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
11:44 AM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
10:39 AM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
8:52 AM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/25/2024
8:24 AM | STATE STREET CORP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
01/23/2024
12:17 PM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
9:51 AM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
9:52 AM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
6:07 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:11 PM | Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
4:14 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/06/2023
1:34 PM | BlackRock Inc. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
09/21/2023
6:35 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2023
6:35 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
4:00 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K/A | |
09/05/2023
7:10 PM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
7:12 PM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
7:13 PM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
7:15 PM | Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
11:54 AM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
11:43 AM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
11:34 AM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
7:35 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
7:07 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
12:39 PM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2023
11:58 AM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Incredible Opportunity to Retire FAST! (Ad) A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide |
